Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase.
Timothy SpelmanSara EichauRaed AlroughaniSerkan OzakbasSamia J KhouryFrancesco PattiEva Kubala HavrdovaCavit BozMurat TerziJens KuhlePierre GrammondJeanette Lechner-ScottOrla GrayMaria Pia AmatoGuy LaureysVahid ShaygannejadRobert HydeHaijue WangIvan BozinNicholas BelvisoChao QuanFeng ZengAnneke Van Der WaltHelmut Butzkuevennull nullPublished in: Multiple sclerosis journal - experimental, translational and clinical (2024)
This analysis supports the use of DMF to treat patients with relapsing forms of MS, and may have implications for MS practices in countries where NSIS are commonly used to treat RRMS.